BRPI0821597A2 - Métodos para quantificar a quantidade de proteína derivada de plasma e proteína recombinante em uma amostra e para diferenciar proteína derivada de plasma e proteína recombinante em uma amostra, e, kit. - Google Patents

Métodos para quantificar a quantidade de proteína derivada de plasma e proteína recombinante em uma amostra e para diferenciar proteína derivada de plasma e proteína recombinante em uma amostra, e, kit.

Info

Publication number
BRPI0821597A2
BRPI0821597A2 BRPI0821597-9A BRPI0821597A BRPI0821597A2 BR PI0821597 A2 BRPI0821597 A2 BR PI0821597A2 BR PI0821597 A BRPI0821597 A BR PI0821597A BR PI0821597 A2 BRPI0821597 A2 BR PI0821597A2
Authority
BR
Brazil
Prior art keywords
protein
sample
plasma derived
recombinant protein
quantifying
Prior art date
Application number
BRPI0821597-9A
Other languages
English (en)
Inventor
Alfred Weber
Peter Turecek
Hans-Peter Schwarz
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of BRPI0821597A2 publication Critical patent/BRPI0821597A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4724—Lectins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0821597-9A 2007-12-27 2008-12-22 Métodos para quantificar a quantidade de proteína derivada de plasma e proteína recombinante em uma amostra e para diferenciar proteína derivada de plasma e proteína recombinante em uma amostra, e, kit. BRPI0821597A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1709107P 2007-12-27 2007-12-27
PCT/US2008/087934 WO2009086262A1 (en) 2007-12-27 2008-12-22 Methods for differentiating plasma-derived protein from recombinant protein in a sample

Publications (1)

Publication Number Publication Date
BRPI0821597A2 true BRPI0821597A2 (pt) 2015-06-16

Family

ID=40451315

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821597-9A BRPI0821597A2 (pt) 2007-12-27 2008-12-22 Métodos para quantificar a quantidade de proteína derivada de plasma e proteína recombinante em uma amostra e para diferenciar proteína derivada de plasma e proteína recombinante em uma amostra, e, kit.

Country Status (11)

Country Link
US (2) US8114633B2 (pt)
EP (1) EP2223108B1 (pt)
JP (3) JP2011508239A (pt)
KR (1) KR101627157B1 (pt)
AU (1) AU2008345558B2 (pt)
BR (1) BRPI0821597A2 (pt)
CA (1) CA2709073A1 (pt)
DK (1) DK2223108T3 (pt)
ES (1) ES2587742T3 (pt)
NZ (1) NZ585530A (pt)
WO (1) WO2009086262A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470318B2 (en) 2005-11-07 2013-06-25 The Rockefeller University Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
CA2647524C (en) 2006-04-05 2019-11-26 The Rockefeller University Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
NZ585530A (en) * 2007-12-27 2012-06-29 Baxter Int Methods for differentiating plasma-derived protein from recombinant protein in a sample
WO2011060242A2 (en) 2009-11-13 2011-05-19 Talecris Biotherapeutics, Inc. Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
US8785139B2 (en) * 2011-05-18 2014-07-22 Baxter International Inc. Modification-dependent activity assays
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
EP3265241B1 (en) * 2015-03-06 2023-10-25 Magna International Inc. Tailored material properties using infrared radiation and infrared absorbent coatings

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391904A (en) * 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US5225542A (en) * 1984-10-23 1993-07-06 Max-Planck Gesellschaft Zur Foerderung Der Wissenschaften E.V. Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells
US5395924A (en) * 1986-03-20 1995-03-07 Dana-Farber Cancer Institute, Inc. Blocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicity
US6048729A (en) * 1987-05-01 2000-04-11 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
US5047335A (en) * 1988-12-21 1991-09-10 The Regents Of The University Of Calif. Process for controlling intracellular glycosylation of proteins
US6063630A (en) * 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
JPH07325083A (ja) * 1994-05-31 1995-12-12 Nakarai Tesuku Kk 糖タンパク質の特定糖鎖割合の測定方法
US6238908B1 (en) * 1995-06-07 2001-05-29 Aastrom Biosciences, Inc. Apparatus and method for maintaining and growth biological cells
TWI235158B (en) * 1997-09-01 2005-07-01 Kirin Brewery Human thrombopoietin produced by human established cell lines, processes foe preparing the same, and pharmaceutical composition comprising the same
WO1999064072A1 (de) 1998-06-10 1999-12-16 Baxter Aktiengesellschaft Konjugat, bestehend aus einem lektin und einem blutgerinnungsfaktor
JP4514919B2 (ja) * 2000-08-14 2010-07-28 力 大山 前立腺特異抗原の糖鎖構造の違いに基づく前立腺癌と前立腺肥大とを識別する方法
CN101163506B (zh) * 2004-12-27 2012-09-26 巴克斯特国际公司 聚合物-von Willebrand因子偶联物
US7838634B2 (en) * 2005-04-15 2010-11-23 Van Andel Research Institute Methods for measuring glycan levels of proteins
JP4385149B2 (ja) * 2005-05-11 2009-12-16 独立行政法人理化学研究所 血清糖蛋白質をバイオマーカーとするアルツハイマー病の診断薬
NZ585530A (en) * 2007-12-27 2012-06-29 Baxter Int Methods for differentiating plasma-derived protein from recombinant protein in a sample

Also Published As

Publication number Publication date
CA2709073A1 (en) 2009-07-09
EP2223108A1 (en) 2010-09-01
JP2011508239A (ja) 2011-03-10
WO2009086262A1 (en) 2009-07-09
AU2008345558A1 (en) 2009-07-09
NZ585530A (en) 2012-06-29
US20120040379A1 (en) 2012-02-16
EP2223108B1 (en) 2016-04-06
KR101627157B1 (ko) 2016-06-03
KR20100117575A (ko) 2010-11-03
JP2015194501A (ja) 2015-11-05
JP2018017736A (ja) 2018-02-01
ES2587742T3 (es) 2016-10-26
US8114633B2 (en) 2012-02-14
DK2223108T3 (en) 2016-07-18
US20090221100A1 (en) 2009-09-03
JP6212519B2 (ja) 2017-10-11
US8828676B2 (en) 2014-09-09
AU2008345558B2 (en) 2014-08-21

Similar Documents

Publication Publication Date Title
BRPI0821597A2 (pt) Métodos para quantificar a quantidade de proteína derivada de plasma e proteína recombinante em uma amostra e para diferenciar proteína derivada de plasma e proteína recombinante em uma amostra, e, kit.
IL185547A0 (en) Lipocalin protein
WO2010011944A3 (en) Protein screeing methods
ZA201001789B (en) Composition and methods for use for antibodies against sclerostin
BRPI0819338A2 (pt) Preparações, métodos e kits úteis para o tratamento de tosse
EP2021467A4 (en) CHIMERIC PCSK9 PROTEINS, THESE INCLUDING CELLS AND TEST METHODS THEREWITH
BRPI0809655A2 (pt) Método para tratar uma condição em um mamífero, composição farmacêutica, e, kit
BRPI0812446A2 (pt) Métodos para aperfeiçoamento de propriedades de proteína múltiplas
BRPI0813216A2 (pt) Inibidores de proteínas cinases e métodos para usá-los.
DK2139987T5 (da) Fremgangsmåder til proteinfremstilling med anti-senescens-forbindelser
BRPI1016065A2 (pt) "processo para detectar, de maneira quantitativa, uma proteína alvo em uma amostra."
BRPI0807220B1 (pt) composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição
BRPI0719272A2 (pt) Composição de enzima, e, método para preparar uma composição de enzima.
SI2183599T1 (sl) Visoko občutljiv imunološki preskus in komplet za določanje peptidov in proteinov biološkega interesa
GB0802474D0 (en) Mutant proteins and methods for selecting them
BRPI0908734A2 (pt) Métodos para a identificação de dna genômico em uma amostra e para a indentificação de polimorfismos, e, kit
DK2024747T3 (da) Anvendelse af protein SATB2 som prognotisk markør for colerectal cancer
BRPI0614961A2 (pt) aptâmero, método, e, composição
GB0611116D0 (en) Proteins
BRPI0718068A2 (pt) Material compósito, e, método
IL189685A0 (en) Compositions and methods for analyzing protein interactions
GB0725153D0 (en) Protein analysis
BRPI0921147A2 (pt) métodos para a detecção de espécies de rna alvo pouco abundante em uma amostra biológica, e para a detecção de uma contaminação com micoplasma em uma amostra biológica, e, kit.
GB0601976D0 (en) Proteins
EP2048506A4 (en) MARKERS FOR POSTPRANDIAL HYPERGLYKEMIA, METHOD OF DETERMINING THEREOF AND USE THEREOF

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.